Osteosclerosis congenita

From WikiMD's Food, Medicine & Wellness Encyclopedia

Osteosclerosis Congenita is a rare, inherited bone disorder characterized by an increase in bone density. It is also known as Albers-Schönberg disease and is a type of osteopetrosis.

Etiology[edit | edit source]

Osteosclerosis Congenita is caused by mutations in the CLCN7 gene. This gene provides instructions for making a protein that is involved in the breakdown and reformation of bones. Mutations in the CLCN7 gene disrupt this process, leading to abnormally dense, brittle bones.

Symptoms[edit | edit source]

The symptoms of Osteosclerosis Congenita can vary widely, even among members of the same family. Common symptoms include recurrent bone fractures, short stature, dental abnormalities, and anemia. Some individuals may also have vision or hearing loss due to the compression of nerves.

Diagnosis[edit | edit source]

Diagnosis of Osteosclerosis Congenita is typically made through a combination of clinical examination, family history, and imaging studies such as X-rays or CT scans. Genetic testing can confirm the diagnosis.

Treatment[edit | edit source]

There is currently no cure for Osteosclerosis Congenita. Treatment is focused on managing symptoms and preventing complications. This may include physical therapy, pain management, and surgical intervention for fractures or other bone abnormalities.

Prognosis[edit | edit source]

The prognosis for individuals with Osteosclerosis Congenita varies depending on the severity of symptoms. Some individuals may have a normal lifespan with few complications, while others may experience significant health problems.

See Also[edit | edit source]

References[edit | edit source]

NIH genetic and rare disease info[edit source]

Osteosclerosis congenita is a rare disease.





Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD